21 - Endocarditis Flashcards
Catheter-Related Bacteremia/Sepsis
Vs
Localized Catheter site infection
Catheter-related bacteremia/sepsis
positive catheter culture
•ositive peripheral blood culture
same microorganism isolated in both 1 & 2
Localized catheter site infection
Clinically or microbiologically proved infection at the catheter exit site
(e.g., cellulitis, purulence, tunnelitis, pocket infections)
No systemic signs
Trans-THORACIC echocardiogram
less invasive
QUICKER
better at
quantifying hemodynamic dysfunction
Treatment for:
STREP
Veridans / Gallolyticus / Abiotrophia / Granulicatella
NVE
(native valve endocarditis)
- *PCN - Intermediate Resistance**
- *MIC > 0.12 , <0.5**
- *Penicillin G Sodium**
- *24 million** units per 24 hours
- *4 WEEKS**
++PLUS++
- *Gentamicin**
- *3mg/kg** per 24 hours
- *2 WEEKS**
Indications for
LONG-TERM CATHETERS
PICC
Port-a-cath
Groshong = CLosed end
Hickman = open end
- Lack of short term peripheral venous access (e.g, IV drug users)
- Infusion of hyperosmolar solutions (e.g., TPNs)
- Infusion of vessicant/ irritant drugs (e.g., certain chemotherapy)
- Long-term IV therapy (e.g., treatment of endocarditis)
- Infusion of intermittent drug therapy (e.g., chemotherapy)
- Use of continuous ambulatory drug pumps (e.g., TPN)
- Patient, physician or nursing preference
- Geographic location (e.g., lives out in the country)
Prevention** **for Infective Endocarditis
Unable to take ORAL
Prosthetic Valve or Material
previous IE
CHD
Dental procedures
- *Ampicillin**
- *2gm IM or IV**
1 hour before procedure
Bacterial ETIOLOGY
of
CR-BSI
Coagulase Negative STAPHylococcus
All Gram Negative Bacteria
Enterococci = STAPH.Areus
Candida
CR-BSI TREATMENT:
STAPHYLOCOCCUS AUREUS
RESISTANCE
Methicillin Resistant Strains
- *Vancomycin**
- *15mg/kg q12**
OR
- *Daptomycin**
- *6-8mg/kg**
2-6 WEEKS
REMOVE LINE
Treatment for:
GRAM NEGATIVE BACILLI
Infective Endocarditis
- *B-Lactam_ + _AminoGlycoside**
- *6 WEEKS**
REQUIRES VALVE REPLACEMENT
Treatment for:
GRAM NEGATIVE BACILLI
Infective Endocarditis
- *B-Lactam_ + _AminoGlycoside**
- *6 WEEKS**
REQUIRES VALVE REPLACEMENT
Treatment for:
STAPH Aureus
Coagulase-Negative Staphylococci
NVE
(Native Valve Endocarditis)
PCN ALLERGY
- *Vancomycin**
- *30mg/kg** QD
- *6 WEEKS**
Treatment for:
Enterococcuus
Coagulase-Negative Staphylococci
PVE** or **NVE
(Prosthetic OR native)
RESISTANT STRAINS
to PCN / Vancomycin / Gentamicin
- *LINEZOLID**
- *600mg** IV or ORAL q12 hr
- *>** 6 Weeks
OR
- *DAPTOMYCIN**
- *10-12 mg/kg per dose**
- *>** 6 Weeks
trans-ESOPHAGEAL echocardiogram
more SENSITIVE
cost-effective
Recommended in patients with:
PROSTHETIC Valves
Previous Cardiothoracic Surgery
COPD
MORBID OBESITY
Prevention** **for Infective Endocarditis
ORAL
Prosthetic Valve or Material
previous IE
CHD
Dental procedures
- *AMOXICILLIN**
- *2gm**
1 hour before procedure
Treatment for:
STAPH Aureus
Coagulase-Negative Staphylococci
PVE
(Prosthetic)
RESISTANT STRAINS
- *PVE STAPH = 3 DRUGS** + >6 week treatment
- Resistant –> vanco instead of oxacillin*
VANCOMYCIN
30mg/kg per 24hr in 2dd
> 6 WEEKS
++++
Rifampin
900mg per 24 hours
> 6 WEEKS
+++
Gentamicin
3mg/kg per 24 hours
2 WEEKS
Prevention** **for Infective Endocarditis
PCN / Ampicillin Allergy
UNABLE TO TAKE ORAL
Prosthetic Valve or Material
previous IE
CHD
Dental procedures
- *CLINDAMYCIN**
- *600mg IM or IV**
Risk Factors
Infective Endocarditis
Heart Disease
Rheumatic / Congenital / Acquired
Patent Ductus - Mitral Valve prolapse
Prosthetic Valves
Previous Bacterial endocarditis
ways bacteria could be introduced:
Indwelling Catheters
IV DRUG USE
DENTAL / SURGICAL procedures
Treatment for:
STREP
Veridans / Gallolyticus / Abiotrophia / Granulicatella
PVE
(Proshetic Valve Endocarditis)
- *PCN SENSITIVE**
- *MIC < 0.12**
- *Penicillin G sodium**
- *24 million** units for 24 hours
- *6 WEEKS**
with or without
- *Gentamicin**
- *3mg/kg** per 24 hours in 1 dose
- *2 WEEKS**
When should the
Catheter be PULLED
for
CR-BSI
Short Term Use
Supperative Thrombophlebitis
Severe Sepsis / Endocarditis / Osteomylitis
+POS+ Blood cultures after 72 hours
& receiving ABx therapy